Coordinate induction of both cytochrome P4503A and MDRI by St John's wort in healthy subjects

被引:201
作者
Dresser, GK
Schwarz, UI
Wilkinson, GR
Kim, RB
机构
[1] Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Dept Pharmacol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Dept Med, Nashville, TN 37232 USA
关键词
D O I
10.1067/mcp.2003.10
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Many drugs are cosubstrates of cytochrome P450 (CYP) 3A and MDR1; furthermore, their Back disposition is markedly affected by pretreatment with inducing agents, including St John's wort. Such drug interactions reflect induction of both proteins through a common mechanism involving the steroid X receptor/pregnane X receptor. However, the relative contributions of enhanced metabolism and efflux transport to the overall induction process are unknown. Methods: The effects of 12 days' pretreatment with St John's wort on the disposition of selected in vivo probe drugs were determined in 21 young healthy subjects. Midazolam after oral and intravenous administration was used to assess CYP3A activity in both the intestinal epithelium and the liver, whereas the disposition of fexofenadine after an. oral dose was assumed to be a measure of MDR1 function, and the oral plasma concentration-time profile of cyclosporine (INN, ciclosporin) was considered to reflect both CYP3A and MDR1 activities. Results: St John's wort markedly affected the plasma concentration-time profiles of all of the drugs, with associated increases in their clearance. With midazolam, the enhancement was considerably less after intravenous administration (approximately 1.5-fold) than after oral administration (approximately 2.7-fold), and estimated intestinal and hepatic extraction ratios were higher by approximately 1.2- to 1.4-fold. By contrast, the, oral clearances of fexofenadine and cyclosporine were equally increased by approximately 1.6-fold and 1.9-fold, respectively; these changes were both statistically less than for midazolam's oral clearance and greater than its estimated intestinal extraction. Conclusions: Although the disposition of all 3 drugs was. altered by,St John's wort, the extent of induction measured by oral clearance was different with CYP3A activity (midazolam), apparently increasing more than MDR1 function (fexofenadine), whereas with cyclosporine the change in oral clearance appeared to be more closely associated with the increase in MDR1 rather than CYP3A, despite the fact that both proteins are importantly involved in its disposition. These discordances indicate that, although a common molecular mechanism may be involved, the quantitative aspects of-induction are complex and depend on the particular drug and the relative contributions of CYP3A and MDR1 in its disposition.
引用
收藏
页码:41 / 50
页数:10
相关论文
共 48 条
  • [1] *AM BOT COUN, 1998, COMPL GERM COMM E MO
  • [2] Rifampin drastically reduces plasma concentrations and effects of oral midazolam
    Backman, JT
    Olkkola, KT
    Neuvonen, PJ
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (01) : 7 - 13
  • [3] Drug interaction between St. John's wort and cyclosporine
    Barone, GW
    Gurley, BJ
    Ketel, BL
    Lightfoot, ML
    Abul-Ezz, SR
    [J]. ANNALS OF PHARMACOTHERAPY, 2000, 34 (09) : 1013 - 1016
  • [4] The drug efflux-metabolism alliance: biochemical aspects
    Benet, LZ
    Cummins, CL
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2001, 50 : S3 - S11
  • [5] St John's wort interaction with digoxin
    Cheng, TO
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (16) : 2548 - 2548
  • [6] DETERMINATION OF TERFENADINE AND TERFENADINE ACID METABOLITE IN PLASMA USING SOLID-PHASE EXTRACTION AND HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION
    COUTANT, JE
    WESTMARK, PA
    NARDELLA, PA
    WALTER, SM
    OKERHOLM, RA
    [J]. JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1991, 570 (01): : 139 - 148
  • [7] Unmasking the dynamic interplay between intestinal P-glycoprotein and CYP3A4
    Cummins, CL
    Jacobsen, W
    Benet, LZ
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 300 (03) : 1036 - 1045
  • [8] Cvetkovic M, 1999, DRUG METAB DISPOS, V27, P866
  • [9] Drug interaction between St John's wort and nevirapine
    de Maat, MMR
    Hoetelmans, RMW
    Mathôt, RAA
    van Gorp, ECM
    Meenhorst, PL
    Mulder, JW
    Beijnen, JH
    [J]. AIDS, 2001, 15 (03) : 420 - 421
  • [10] St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4
    Dürr, D
    Stieger, B
    Kullak-Ublick, GA
    Rentsch, KM
    Steinert, HC
    Meier, PJ
    Fattinger, K
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (06) : 598 - 604